Literature DB >> 33746637

Amyotrophic Lateral Sclerosis: Integrated care provides the best quality of life.

Jonathan R Brent1, Senda Ajroud-Driss1.   

Abstract

Entities:  

Year:  2019        PMID： 33746637      PMCID： PMC7978460     

Source DB:  PubMed          Journal:  Pract Neurol (Fort Wash Pa)        ISSN： 1540-1367


× No keyword cloud information.
  24 in total

Review 1.  Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease.

Authors:  Louisa Ng; Fary Khan; Carolyn A Young; Mary Galea
Journal:  Cochrane Database Syst Rev       Date:  2017-01-10

Review 2.  Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease.

Authors:  Nigel L Ashworth; L E Satkunam; Dan Deforge
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

3.  Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial.

Authors:  Anne-Marie Wills; Jane Hubbard; Eric A Macklin; Jonathan Glass; Rup Tandan; Ericka P Simpson; Benjamin Brooks; Deborah Gelinas; Hiroshi Mitsumoto; Tahseen Mozaffar; Gregory P Hanes; Shafeeq S Ladha; Terry Heiman-Patterson; Jonathan Katz; Jau-Shin Lou; Katy Mahoney; Daniela Grasso; Robert Lawson; Hong Yu; Merit Cudkowicz
Journal:  Lancet       Date:  2014-02-28       Impact factor: 79.321

Review 4.  Respiratory therapies for amyotrophic lateral sclerosis: a primer.

Authors:  Kirsten L Gruis; Noah Lechtzin
Journal:  Muscle Nerve       Date:  2012-09       Impact factor: 3.217

5.  Tracheostomy mechanical ventilation in patients with amyotrophic lateral sclerosis: clinical features and survival analysis.

Authors:  Rossella Spataro; Valeria Bono; Santino Marchese; Vincenzo La Bella
Journal:  J Neurol Sci       Date:  2012-09-16       Impact factor: 3.181

Review 6.  Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  R G Miller; C E Jackson; E J Kasarskis; J D England; D Forshew; W Johnston; S Kalra; J S Katz; H Mitsumoto; J Rosenfeld; C Shoesmith; M J Strong; S C Woolley
Journal:  Neurology       Date:  2009-10-13       Impact factor: 9.910

Review 7.  Amyotrophic lateral sclerosis.

Authors:  Orla Hardiman; Ammar Al-Chalabi; Adriano Chio; Emma M Corr; Giancarlo Logroscino; Wim Robberecht; Pamela J Shaw; Zachary Simmons; Leonard H van den Berg
Journal:  Nat Rev Dis Primers       Date:  2017-10-05       Impact factor: 52.329

8.  Sialorrhea in patients with ALS: current treatment options.

Authors:  Giancarlo Garuti; Fabrizio Rao; Viviana Ribuffo; Valeria A Sansone
Journal:  Degener Neurol Neuromuscul Dis       Date:  2019-03-20

Review 9.  Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis.

Authors:  Johannes Dorst; Albert C Ludolph; Annemarie Huebers
Journal:  Ther Adv Neurol Disord       Date:  2017-10-09       Impact factor: 6.570

Review 10.  Amyotrophic lateral sclerosis: improving care with a multidisciplinary approach.

Authors:  Anne Hogden; Geraldine Foley; Robert D Henderson; Natalie James; Samar M Aoun
Journal:  J Multidiscip Healthc       Date:  2017-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.